rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

Bal Pharma Ltd.

524824 BALPHARMA Group (B)

26 Jul,15:28
117.55
1.45 (1.25%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

Bal Pharma Ltd.

BUYSELL

4,639 116.10 119.25 - 117.00 132.20 - 81.50 185.73
NSE | BSE

Bal Pharma Ltd.

BALPHARMA

26 Jul,15:57
117.30
1.45 (1.25%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

Bal Pharma Ltd.

BUYSELL

28,604 115.85 119.78 - 114.01 132.45 - 81.20 3,369,265.16

News for Bal Pharma Ltd.

Uddhav Thackeray...
Uddhav Thackeray Claims Fadnavis Promised to Groom Aaditya as CM
Uddhav Thackeray claims Devendra Fadnavis promised to groom Aaditya Thackeray as CM in 2019, sparking a war of words between the two leaders. Fadnavis denies the claim, calling it 'delirious'.
Apr 21, 2024 08:26
Uddhav Thackeray:...
Uddhav Thackeray: Fadnavis Promised to Groom Aaditya as CM
Shiv Sena (UBT) leader Uddhav Thackeray claims Devendra Fadnavis promised to groom his son Aaditya as CM in 2019. Fadnavis denies the claim, calling Thackeray 'delirious'.
Apr 20, 2024 22:49
BJP Never Faced...
BJP Never Faced Split, Focused on Ideology: Fadnavis
Maharashtra Deputy CM Devendra Fadnavis asserts that BJP's ideology has kept it united, unlike other parties like Shiv Sena and NCP which have witnessed splits. He also emphasizes the party's...
Apr 06, 2024 12:13
BJP Never Faced...
BJP Never Faced Split, Focused on Ideology: Fadnavis
Maharashtra Deputy CM Devendra Fadnavis asserts BJP never faced internal divisions, highlighting the party's ideological foundation and its commitment to national interests. He also praises PM...
Apr 06, 2024 12:12
Delhi Economic...
Delhi Economic Survey: 11 Hospital Projects Underway
Delhi's Economic Survey reveals 11 new hospital construction projects underway, alongside hospital upgrades and data on birth, death, and dengue rates. Read more.
Mar 01, 2024 17:03

More News for Bal Pharma Ltd. »

(Rs. Crore)

Financial Results of Bal Pharma Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales338.54303.10280.37249.31170.67
Operating profit32.4426.0323.2026.326.26
Interest15.2412.1610.4011.9612.42
Gross profit20.5616.0319.2917.06-2.54
EPS (Rs)6.503.905.786.14-6.72

See more in Research Center »

News for Pharmaceuticals and health care

Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05
Kargil Vijay...
Kargil Vijay Diwas: India Post Releases Commemorative Stamp
India Post commemorates the 25th anniversary of Kargil Vijay Diwas with a special postage stamp, honoring the bravery of Indian armed forces.
Jul 26, 2024 22:04

More News »

Top News

G20 Agrees to Tax...
G20 Agrees to Tax Super-Rich, Brazil Leads Effort
Finance ministers from G20 nations agree to work toward taxing the super-rich, a significant step toward addressing global inequality. Brazil's proposal for a 2% minimum tax on billionaires is...
Jul 27, 2024 03:35
Aditya Birla...
Aditya Birla Group Targets USD 25 Billion Consumer Business Revenue
Aditya Birla Group aims to reach USD 25 billion in consumer business revenue in the next 5 years, driven by diversification and portfolio strengthening. The group is focused on financial services,...
Jul 26, 2024 22:32
Sebi Confirms...
Sebi Confirms Order Against 12 in V Marc India Fraud
Sebi confirms its order against 12 entities, including V Marc India's promoter, for a fraudulent scheme to manipulate stock prices.
Jul 26, 2024 22:25
PM GatiShakti...
PM GatiShakti Evaluates 5 Infra Projects: Road, Rail
Network Planning Group (NPG) has evaluated 5 infrastructure projects, including road and rail, under the PM GatiShakti initiative, focusing on integrated planning.
Jul 26, 2024 22:10
Fortune Wealth...
Fortune Wealth Targets Rs 500 cr Multi-Cap Fund
Fortune Wealth aims to raise Rs 500 crore for its multi-cap portfolio fund within 5 months. The fund, launched in June 2024, has already gathered Rs 320 crore.
Jul 26, 2024 22:05

More Top News »

Report Card

PE Ratios
18.09
EPS (Rs.)
6.50
Sales (Rs. Cr)
94.58
Face Value (Rs.)
10
Net Profit Margin (%)
2.02
Last Bonus
Last Dividend(%)
12
Return on Average Equity
6.47

Compare 'Bal Pharma Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,665.20
  • Compare
  • Divi's Laboratories Ltd.
  • 4,549.75
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,205.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,854.20
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 3,087.85
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,388.60
  • Compare
  • Max Healthcare Institute Ltd.
  • 926.50
  • Compare
  • Alkem Laboratories Ltd.
  • 5,178.80
  • Compare

Most Active

  • Change (Rs.)
  •  

Bal Pharma Ltd. performance snapshot

If you had invested Rs.  in Bal Pharma Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add Bal Pharma Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add Bal Pharma Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close